nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—Pain in jaw—Capecitabine—esophageal cancer	0.0194	0.0301	CcSEcCtD
Estazolam—Paraesthesia oral—Capecitabine—esophageal cancer	0.0135	0.0209	CcSEcCtD
Estazolam—Ulcer—Cisplatin—esophageal cancer	0.00908	0.0141	CcSEcCtD
Estazolam—Hearing impaired—Cisplatin—esophageal cancer	0.00902	0.014	CcSEcCtD
Estazolam—Pain—Carboplatin—esophageal cancer	0.00893	0.0138	CcSEcCtD
Estazolam—Laryngitis—Capecitabine—esophageal cancer	0.00878	0.0136	CcSEcCtD
Estazolam—Body temperature increased—Carboplatin—esophageal cancer	0.00826	0.0128	CcSEcCtD
Estazolam—Vaginal discharge—Methotrexate—esophageal cancer	0.00774	0.012	CcSEcCtD
Estazolam—Eye irritation—Capecitabine—esophageal cancer	0.00741	0.0115	CcSEcCtD
Estazolam—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.00706	0.0109	CcSEcCtD
Estazolam—Nocturia—Capecitabine—esophageal cancer	0.00682	0.0106	CcSEcCtD
Estazolam—Ulcer—Capecitabine—esophageal cancer	0.00669	0.0104	CcSEcCtD
Estazolam—Hearing impaired—Capecitabine—esophageal cancer	0.00665	0.0103	CcSEcCtD
Estazolam—Amnesia—Cisplatin—esophageal cancer	0.00663	0.0103	CcSEcCtD
Estazolam—Coordination abnormal—Capecitabine—esophageal cancer	0.00645	0.00998	CcSEcCtD
Estazolam—Neck pain—Capecitabine—esophageal cancer	0.00641	0.00992	CcSEcCtD
Estazolam—Stupor—Methotrexate—esophageal cancer	0.00631	0.00977	CcSEcCtD
Estazolam—Melaena—Capecitabine—esophageal cancer	0.00618	0.00957	CcSEcCtD
Estazolam—Urinary incontinence—Capecitabine—esophageal cancer	0.00611	0.00946	CcSEcCtD
Estazolam—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00611	0.00946	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00561	0.00869	CcSEcCtD
Estazolam—Nasopharyngitis—Cisplatin—esophageal cancer	0.00557	0.00863	CcSEcCtD
Estazolam—Abnormal vision—Capecitabine—esophageal cancer	0.00552	0.00855	CcSEcCtD
Estazolam—Mental disability—Capecitabine—esophageal cancer	0.00549	0.0085	CcSEcCtD
Estazolam—Ear pain—Capecitabine—esophageal cancer	0.00538	0.00834	CcSEcCtD
Estazolam—Sleep disorder—Capecitabine—esophageal cancer	0.00531	0.00822	CcSEcCtD
Estazolam—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00525	0.00813	CcSEcCtD
Estazolam—Photosensitivity—Capecitabine—esophageal cancer	0.00523	0.0081	CcSEcCtD
Estazolam—Vascular purpura—Capecitabine—esophageal cancer	0.00514	0.00795	CcSEcCtD
Estazolam—Oliguria—Methotrexate—esophageal cancer	0.00511	0.00792	CcSEcCtD
Estazolam—Eye pain—Capecitabine—esophageal cancer	0.00509	0.00788	CcSEcCtD
Estazolam—Ulcer—Methotrexate—esophageal cancer	0.00498	0.00771	CcSEcCtD
Estazolam—Libido decreased—Capecitabine—esophageal cancer	0.00495	0.00767	CcSEcCtD
Estazolam—Amnesia—Capecitabine—esophageal cancer	0.00489	0.00757	CcSEcCtD
Estazolam—Increased appetite—Capecitabine—esophageal cancer	0.00489	0.00757	CcSEcCtD
Estazolam—Thirst—Capecitabine—esophageal cancer	0.00483	0.00747	CcSEcCtD
Estazolam—Purpura—Capecitabine—esophageal cancer	0.00477	0.00738	CcSEcCtD
Estazolam—Arthritis—Capecitabine—esophageal cancer	0.00473	0.00732	CcSEcCtD
Estazolam—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00471	0.00729	CcSEcCtD
Estazolam—Melaena—Methotrexate—esophageal cancer	0.0046	0.00713	CcSEcCtD
Estazolam—Diplopia—Capecitabine—esophageal cancer	0.00459	0.00711	CcSEcCtD
Estazolam—Pain in extremity—Capecitabine—esophageal cancer	0.00459	0.00711	CcSEcCtD
Estazolam—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00456	0.00706	CcSEcCtD
Estazolam—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00455	0.00704	CcSEcCtD
Estazolam—Mood swings—Capecitabine—esophageal cancer	0.00435	0.00674	CcSEcCtD
Estazolam—Ataxia—Capecitabine—esophageal cancer	0.00432	0.00669	CcSEcCtD
Estazolam—Dry skin—Capecitabine—esophageal cancer	0.00421	0.00652	CcSEcCtD
Estazolam—Visual impairment—Cisplatin—esophageal cancer	0.00416	0.00643	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00414	0.00641	CcSEcCtD
Estazolam—Nasopharyngitis—Capecitabine—esophageal cancer	0.00411	0.00636	CcSEcCtD
Estazolam—Gastritis—Capecitabine—esophageal cancer	0.00407	0.00629	CcSEcCtD
Estazolam—Tinnitus—Cisplatin—esophageal cancer	0.00402	0.00622	CcSEcCtD
Estazolam—Lymphadenopathy—Methotrexate—esophageal cancer	0.00401	0.00621	CcSEcCtD
Estazolam—Flushing—Cisplatin—esophageal cancer	0.004	0.0062	CcSEcCtD
Estazolam—Asthma—Capecitabine—esophageal cancer	0.00397	0.00615	CcSEcCtD
Estazolam—Photosensitivity—Methotrexate—esophageal cancer	0.0039	0.00603	CcSEcCtD
Estazolam—Arrhythmia—Cisplatin—esophageal cancer	0.00385	0.00596	CcSEcCtD
Estazolam—Malnutrition—Cisplatin—esophageal cancer	0.00375	0.00581	CcSEcCtD
Estazolam—Flatulence—Cisplatin—esophageal cancer	0.0037	0.00573	CcSEcCtD
Estazolam—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00362	0.00561	CcSEcCtD
Estazolam—Weight increased—Capecitabine—esophageal cancer	0.00361	0.00559	CcSEcCtD
Estazolam—Muscle spasms—Cisplatin—esophageal cancer	0.00361	0.00559	CcSEcCtD
Estazolam—Weight decreased—Capecitabine—esophageal cancer	0.00359	0.00556	CcSEcCtD
Estazolam—Depression—Capecitabine—esophageal cancer	0.00353	0.00547	CcSEcCtD
Estazolam—Tremor—Cisplatin—esophageal cancer	0.00352	0.00544	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00351	0.00543	CcSEcCtD
Estazolam—Ill-defined disorder—Cisplatin—esophageal cancer	0.00348	0.00539	CcSEcCtD
Estazolam—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00347	0.00537	CcSEcCtD
Estazolam—Malaise—Cisplatin—esophageal cancer	0.00338	0.00524	CcSEcCtD
Estazolam—Haematuria—Capecitabine—esophageal cancer	0.00338	0.00523	CcSEcCtD
Estazolam—Leukopenia—Cisplatin—esophageal cancer	0.00336	0.0052	CcSEcCtD
Estazolam—Epistaxis—Capecitabine—esophageal cancer	0.00334	0.00517	CcSEcCtD
Estazolam—Agranulocytosis—Capecitabine—esophageal cancer	0.0033	0.00512	CcSEcCtD
Estazolam—Convulsion—Cisplatin—esophageal cancer	0.00325	0.00503	CcSEcCtD
Estazolam—Mood swings—Methotrexate—esophageal cancer	0.00324	0.00502	CcSEcCtD
Estazolam—Ataxia—Methotrexate—esophageal cancer	0.00322	0.00498	CcSEcCtD
Estazolam—Myalgia—Cisplatin—esophageal cancer	0.0032	0.00495	CcSEcCtD
Estazolam—Rhinitis—Capecitabine—esophageal cancer	0.00319	0.00493	CcSEcCtD
Estazolam—Anxiety—Cisplatin—esophageal cancer	0.00318	0.00493	CcSEcCtD
Estazolam—Discomfort—Cisplatin—esophageal cancer	0.00316	0.00489	CcSEcCtD
Estazolam—Pharyngitis—Capecitabine—esophageal cancer	0.00315	0.00488	CcSEcCtD
Estazolam—Oedema—Cisplatin—esophageal cancer	0.00306	0.00474	CcSEcCtD
Estazolam—Visual impairment—Capecitabine—esophageal cancer	0.00306	0.00474	CcSEcCtD
Estazolam—Erythema multiforme—Capecitabine—esophageal cancer	0.00301	0.00465	CcSEcCtD
Estazolam—Tinnitus—Capecitabine—esophageal cancer	0.00296	0.00459	CcSEcCtD
Estazolam—Hyperhidrosis—Cisplatin—esophageal cancer	0.00296	0.00458	CcSEcCtD
Estazolam—Asthma—Methotrexate—esophageal cancer	0.00296	0.00458	CcSEcCtD
Estazolam—Flushing—Capecitabine—esophageal cancer	0.00295	0.00457	CcSEcCtD
Estazolam—Chills—Capecitabine—esophageal cancer	0.00285	0.00442	CcSEcCtD
Estazolam—Arrhythmia—Capecitabine—esophageal cancer	0.00284	0.0044	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00279	0.00432	CcSEcCtD
Estazolam—Malnutrition—Capecitabine—esophageal cancer	0.00277	0.00428	CcSEcCtD
Estazolam—Paraesthesia—Cisplatin—esophageal cancer	0.00275	0.00426	CcSEcCtD
Estazolam—Dyspnoea—Cisplatin—esophageal cancer	0.00273	0.00423	CcSEcCtD
Estazolam—Flatulence—Capecitabine—esophageal cancer	0.00273	0.00422	CcSEcCtD
Estazolam—Flunitrazepam—CYP2A6—esophageal cancer	0.00271	0.226	CrCbGaD
Estazolam—Photosensitivity reaction—Methotrexate—esophageal cancer	0.0027	0.00418	CcSEcCtD
Estazolam—Back pain—Capecitabine—esophageal cancer	0.00268	0.00414	CcSEcCtD
Estazolam—Decreased appetite—Cisplatin—esophageal cancer	0.00266	0.00412	CcSEcCtD
Estazolam—Muscle spasms—Capecitabine—esophageal cancer	0.00266	0.00412	CcSEcCtD
Estazolam—Depression—Methotrexate—esophageal cancer	0.00263	0.00407	CcSEcCtD
Estazolam—Pain—Cisplatin—esophageal cancer	0.00262	0.00406	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00261	0.00405	CcSEcCtD
Estazolam—Tremor—Capecitabine—esophageal cancer	0.00259	0.00401	CcSEcCtD
Estazolam—Ill-defined disorder—Capecitabine—esophageal cancer	0.00257	0.00397	CcSEcCtD
Estazolam—Sweating—Methotrexate—esophageal cancer	0.00253	0.00391	CcSEcCtD
Estazolam—Feeling abnormal—Cisplatin—esophageal cancer	0.00252	0.00391	CcSEcCtD
Estazolam—Haematuria—Methotrexate—esophageal cancer	0.00251	0.00389	CcSEcCtD
Estazolam—Malaise—Capecitabine—esophageal cancer	0.0025	0.00386	CcSEcCtD
Estazolam—Epistaxis—Methotrexate—esophageal cancer	0.00249	0.00385	CcSEcCtD
Estazolam—Syncope—Capecitabine—esophageal cancer	0.00248	0.00384	CcSEcCtD
Estazolam—Leukopenia—Capecitabine—esophageal cancer	0.00248	0.00383	CcSEcCtD
Estazolam—Agranulocytosis—Methotrexate—esophageal cancer	0.00246	0.00381	CcSEcCtD
Estazolam—Palpitations—Capecitabine—esophageal cancer	0.00245	0.00379	CcSEcCtD
Estazolam—Loss of consciousness—Capecitabine—esophageal cancer	0.00243	0.00376	CcSEcCtD
Estazolam—Body temperature increased—Cisplatin—esophageal cancer	0.00242	0.00375	CcSEcCtD
Estazolam—Cough—Capecitabine—esophageal cancer	0.00241	0.00374	CcSEcCtD
Estazolam—Arthralgia—Capecitabine—esophageal cancer	0.00236	0.00365	CcSEcCtD
Estazolam—Myalgia—Capecitabine—esophageal cancer	0.00236	0.00365	CcSEcCtD
Estazolam—Chest pain—Capecitabine—esophageal cancer	0.00236	0.00365	CcSEcCtD
Estazolam—Pharyngitis—Methotrexate—esophageal cancer	0.00235	0.00364	CcSEcCtD
Estazolam—Anxiety—Capecitabine—esophageal cancer	0.00235	0.00363	CcSEcCtD
Estazolam—Discomfort—Capecitabine—esophageal cancer	0.00233	0.0036	CcSEcCtD
Estazolam—Dry mouth—Capecitabine—esophageal cancer	0.0023	0.00357	CcSEcCtD
Estazolam—Visual impairment—Methotrexate—esophageal cancer	0.00228	0.00353	CcSEcCtD
Estazolam—Confusional state—Capecitabine—esophageal cancer	0.00228	0.00352	CcSEcCtD
Estazolam—Oedema—Capecitabine—esophageal cancer	0.00226	0.0035	CcSEcCtD
Estazolam—Hypersensitivity—Cisplatin—esophageal cancer	0.00226	0.00349	CcSEcCtD
Estazolam—Erythema multiforme—Methotrexate—esophageal cancer	0.00224	0.00346	CcSEcCtD
Estazolam—Shock—Capecitabine—esophageal cancer	0.00222	0.00344	CcSEcCtD
Estazolam—Tinnitus—Methotrexate—esophageal cancer	0.00221	0.00342	CcSEcCtD
Estazolam—Asthenia—Cisplatin—esophageal cancer	0.0022	0.0034	CcSEcCtD
Estazolam—Hyperhidrosis—Capecitabine—esophageal cancer	0.00218	0.00338	CcSEcCtD
Estazolam—Flurazepam—CYP2A6—esophageal cancer	0.00218	0.182	CrCbGaD
Estazolam—Chills—Methotrexate—esophageal cancer	0.00212	0.00329	CcSEcCtD
Estazolam—Malnutrition—Methotrexate—esophageal cancer	0.00206	0.00319	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00206	0.00319	CcSEcCtD
Estazolam—Paraesthesia—Capecitabine—esophageal cancer	0.00203	0.00314	CcSEcCtD
Estazolam—Dyspnoea—Capecitabine—esophageal cancer	0.00201	0.00312	CcSEcCtD
Estazolam—Back pain—Methotrexate—esophageal cancer	0.00199	0.00308	CcSEcCtD
Estazolam—Dyspepsia—Capecitabine—esophageal cancer	0.00199	0.00308	CcSEcCtD
Estazolam—Decreased appetite—Capecitabine—esophageal cancer	0.00196	0.00304	CcSEcCtD
Estazolam—Vomiting—Cisplatin—esophageal cancer	0.00195	0.00302	CcSEcCtD
Estazolam—Rash—Cisplatin—esophageal cancer	0.00193	0.00299	CcSEcCtD
Estazolam—Pain—Capecitabine—esophageal cancer	0.00193	0.00299	CcSEcCtD
Estazolam—Constipation—Capecitabine—esophageal cancer	0.00193	0.00299	CcSEcCtD
Estazolam—Dermatitis—Cisplatin—esophageal cancer	0.00193	0.00299	CcSEcCtD
Estazolam—Ill-defined disorder—Methotrexate—esophageal cancer	0.00191	0.00296	CcSEcCtD
Estazolam—Feeling abnormal—Capecitabine—esophageal cancer	0.00186	0.00288	CcSEcCtD
Estazolam—Malaise—Methotrexate—esophageal cancer	0.00186	0.00288	CcSEcCtD
Estazolam—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00185	0.00286	CcSEcCtD
Estazolam—Leukopenia—Methotrexate—esophageal cancer	0.00184	0.00285	CcSEcCtD
Estazolam—Nausea—Cisplatin—esophageal cancer	0.00182	0.00282	CcSEcCtD
Estazolam—Cough—Methotrexate—esophageal cancer	0.0018	0.00278	CcSEcCtD
Estazolam—Urticaria—Capecitabine—esophageal cancer	0.00179	0.00278	CcSEcCtD
Estazolam—Body temperature increased—Capecitabine—esophageal cancer	0.00179	0.00276	CcSEcCtD
Estazolam—Abdominal pain—Capecitabine—esophageal cancer	0.00179	0.00276	CcSEcCtD
Estazolam—Convulsion—Methotrexate—esophageal cancer	0.00178	0.00276	CcSEcCtD
Estazolam—Arthralgia—Methotrexate—esophageal cancer	0.00175	0.00271	CcSEcCtD
Estazolam—Myalgia—Methotrexate—esophageal cancer	0.00175	0.00271	CcSEcCtD
Estazolam—Chest pain—Methotrexate—esophageal cancer	0.00175	0.00271	CcSEcCtD
Estazolam—Discomfort—Methotrexate—esophageal cancer	0.00173	0.00268	CcSEcCtD
Estazolam—Confusional state—Methotrexate—esophageal cancer	0.00169	0.00262	CcSEcCtD
Estazolam—Hypersensitivity—Capecitabine—esophageal cancer	0.00166	0.00258	CcSEcCtD
Estazolam—Hyperhidrosis—Methotrexate—esophageal cancer	0.00163	0.00252	CcSEcCtD
Estazolam—Asthenia—Capecitabine—esophageal cancer	0.00162	0.00251	CcSEcCtD
Estazolam—Pruritus—Capecitabine—esophageal cancer	0.0016	0.00247	CcSEcCtD
Estazolam—Ketazolam—ABCB1—esophageal cancer	0.00156	0.13	CrCbGaD
Estazolam—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00153	0.00237	CcSEcCtD
Estazolam—Paraesthesia—Methotrexate—esophageal cancer	0.00151	0.00234	CcSEcCtD
Estazolam—Dyspnoea—Methotrexate—esophageal cancer	0.0015	0.00232	CcSEcCtD
Estazolam—Somnolence—Methotrexate—esophageal cancer	0.00149	0.00231	CcSEcCtD
Estazolam—Dizziness—Capecitabine—esophageal cancer	0.00149	0.00231	CcSEcCtD
Estazolam—Dyspepsia—Methotrexate—esophageal cancer	0.00148	0.00229	CcSEcCtD
Estazolam—Decreased appetite—Methotrexate—esophageal cancer	0.00146	0.00226	CcSEcCtD
Estazolam—Pain—Methotrexate—esophageal cancer	0.00144	0.00223	CcSEcCtD
Estazolam—Vomiting—Capecitabine—esophageal cancer	0.00144	0.00222	CcSEcCtD
Estazolam—Rash—Capecitabine—esophageal cancer	0.00142	0.0022	CcSEcCtD
Estazolam—Dermatitis—Capecitabine—esophageal cancer	0.00142	0.0022	CcSEcCtD
Estazolam—Headache—Capecitabine—esophageal cancer	0.00141	0.00219	CcSEcCtD
Estazolam—Feeling abnormal—Methotrexate—esophageal cancer	0.00139	0.00214	CcSEcCtD
Estazolam—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00137	0.00213	CcSEcCtD
Estazolam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00135	0.00395	CbGpPWpGaD
Estazolam—Nausea—Capecitabine—esophageal cancer	0.00134	0.00208	CcSEcCtD
Estazolam—GABRB1—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00134	0.00391	CbGpPWpGaD
Estazolam—Urticaria—Methotrexate—esophageal cancer	0.00134	0.00207	CcSEcCtD
Estazolam—Abdominal pain—Methotrexate—esophageal cancer	0.00133	0.00206	CcSEcCtD
Estazolam—Body temperature increased—Methotrexate—esophageal cancer	0.00133	0.00206	CcSEcCtD
Estazolam—GABRR1—Neuronal System—GNG7—esophageal cancer	0.00133	0.00388	CbGpPWpGaD
Estazolam—Diazepam—PTGS1—esophageal cancer	0.00132	0.11	CrCbGaD
Estazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00129	0.00376	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.00128	0.00375	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00127	0.00372	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00127	0.00372	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—GNG7—esophageal cancer	0.00126	0.0037	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00125	0.00367	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—ALDH2—esophageal cancer	0.00124	0.00363	CbGpPWpGaD
Estazolam—Hypersensitivity—Methotrexate—esophageal cancer	0.00124	0.00192	CcSEcCtD
Estazolam—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00122	0.00356	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00122	0.00356	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00121	0.00355	CbGpPWpGaD
Estazolam—Asthenia—Methotrexate—esophageal cancer	0.00121	0.00187	CcSEcCtD
Estazolam—GABRR1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.0012	0.0035	CbGpPWpGaD
Estazolam—Pruritus—Methotrexate—esophageal cancer	0.00119	0.00184	CcSEcCtD
Estazolam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00119	0.00347	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—ALDH2—esophageal cancer	0.00119	0.00346	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00118	0.00346	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00114	0.00335	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00114	0.00334	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00114	0.00333	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00113	0.00331	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00111	0.00325	CbGpPWpGaD
Estazolam—Dizziness—Methotrexate—esophageal cancer	0.00111	0.00172	CcSEcCtD
Estazolam—Clobazam—ABCB1—esophageal cancer	0.0011	0.092	CrCbGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00109	0.00319	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00108	0.00316	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00108	0.00316	CbGpPWpGaD
Estazolam—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00108	0.00315	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00107	0.00314	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00107	0.00313	CbGpPWpGaD
Estazolam—Vomiting—Methotrexate—esophageal cancer	0.00107	0.00165	CcSEcCtD
Estazolam—GABRB3—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00107	0.00312	CbGpPWpGaD
Estazolam—Rash—Methotrexate—esophageal cancer	0.00106	0.00164	CcSEcCtD
Estazolam—Dermatitis—Methotrexate—esophageal cancer	0.00106	0.00164	CcSEcCtD
Estazolam—Headache—Methotrexate—esophageal cancer	0.00105	0.00163	CcSEcCtD
Estazolam—GABRG2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00105	0.00306	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00104	0.00305	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—GNG7—esophageal cancer	0.00104	0.00304	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00104	0.00303	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00104	0.00303	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00103	0.00302	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—GNG7—esophageal cancer	0.00103	0.003	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00102	0.00299	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00101	0.00294	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000999	0.00292	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000999	0.00292	CbGpPWpGaD
Estazolam—Nausea—Methotrexate—esophageal cancer	0.000998	0.00155	CcSEcCtD
Estazolam—GABRR2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000989	0.00289	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000989	0.00289	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000984	0.00288	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000981	0.00287	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—ALDH2—esophageal cancer	0.000976	0.00285	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—ALDH2—esophageal cancer	0.000961	0.00281	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000939	0.00275	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000925	0.0027	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000916	0.00268	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000915	0.00267	CbGpPWpGaD
Estazolam—Nitrazepam—ABCB1—esophageal cancer	0.000911	0.076	CrCbGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000911	0.00266	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000904	0.00264	CbGpPWpGaD
Estazolam—GABRG3—Orphan transporters—CREBBP—esophageal cancer	0.000897	0.00262	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00089	0.0026	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—SST—esophageal cancer	0.000889	0.0026	CbGpPWpGaD
Estazolam—GABRB1—Orphan transporters—CREBBP—esophageal cancer	0.000883	0.00258	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000877	0.00256	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—GNG7—esophageal cancer	0.000877	0.00256	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000858	0.00251	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000857	0.00251	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—GNG7—esophageal cancer	0.000852	0.00249	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000849	0.00248	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000841	0.00246	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000837	0.00245	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—GNG7—esophageal cancer	0.000836	0.00245	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—GNG7—esophageal cancer	0.000822	0.0024	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—ALDH2—esophageal cancer	0.000822	0.0024	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000817	0.00239	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—GNG7—esophageal cancer	0.000817	0.00239	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000814	0.00238	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000814	0.00238	CbGpPWpGaD
Estazolam—Flurazepam—ABCB1—esophageal cancer	0.00081	0.0676	CrCbGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000802	0.00235	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000802	0.00235	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000802	0.00235	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—GNG7—esophageal cancer	0.000802	0.00234	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000799	0.00233	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—ALDH2—esophageal cancer	0.000798	0.00233	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000791	0.00231	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000788	0.0023	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000786	0.0023	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—ALDH2—esophageal cancer	0.000784	0.00229	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000783	0.00229	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—ALDH2—esophageal cancer	0.00077	0.00225	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000769	0.00225	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000768	0.00225	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—ALDH2—esophageal cancer	0.000765	0.00224	CbGpPWpGaD
Estazolam—GABRB2—Orphan transporters—CREBBP—esophageal cancer	0.000755	0.00221	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000754	0.0022	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—ALDH2—esophageal cancer	0.000751	0.0022	CbGpPWpGaD
Estazolam—Midazolam—ABCB1—esophageal cancer	0.000751	0.0627	CrCbGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00075	0.00219	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00075	0.00219	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000742	0.00217	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000741	0.00217	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000736	0.00215	CbGpPWpGaD
Estazolam—GABRA5—Orphan transporters—CREBBP—esophageal cancer	0.000733	0.00214	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000728	0.00213	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000723	0.00211	CbGpPWpGaD
Estazolam—GABRA3—Orphan transporters—CREBBP—esophageal cancer	0.00072	0.0021	CbGpPWpGaD
Estazolam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000716	0.00209	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000715	0.00209	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000715	0.00209	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000713	0.00208	CbGpPWpGaD
Estazolam—GABRA2—Orphan transporters—CREBBP—esophageal cancer	0.000708	0.00207	CbGpPWpGaD
Estazolam—GABRB3—Orphan transporters—CREBBP—esophageal cancer	0.000703	0.00205	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000703	0.00205	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—GNG7—esophageal cancer	0.000701	0.00205	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000698	0.00204	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000695	0.00203	CbGpPWpGaD
Estazolam—GABRG2—Orphan transporters—CREBBP—esophageal cancer	0.00069	0.00202	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000686	0.002	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000686	0.002	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000686	0.002	CbGpPWpGaD
Estazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000682	0.00199	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000682	0.00199	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00068	0.00199	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000672	0.00197	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00067	0.00196	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000666	0.00195	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000666	0.00195	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000666	0.00195	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—ALDH2—esophageal cancer	0.000657	0.00192	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000654	0.00191	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000654	0.00191	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000654	0.00191	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000653	0.00191	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000651	0.0019	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000644	0.00188	CbGpPWpGaD
Estazolam—Diazepam—ABCB1—esophageal cancer	0.000643	0.0537	CrCbGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000643	0.00188	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000643	0.00188	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000638	0.00187	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000638	0.00187	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000632	0.00185	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000627	0.00183	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000627	0.00183	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000617	0.0018	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000612	0.00179	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000608	0.00178	CbGpPWpGaD
Estazolam—GABRA1—Orphan transporters—CREBBP—esophageal cancer	0.000603	0.00176	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000599	0.00175	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000572	0.00167	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000563	0.00164	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00056	0.00164	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000552	0.00161	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000548	0.0016	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000548	0.0016	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000534	0.00156	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000529	0.00155	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000526	0.00154	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00052	0.00152	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000519	0.00152	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000505	0.00148	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000501	0.00147	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000496	0.00145	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000495	0.00145	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000488	0.00143	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000487	0.00142	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000484	0.00141	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000484	0.00141	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000475	0.00139	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000471	0.00138	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000458	0.00134	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00045	0.00131	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000442	0.00129	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000439	0.00128	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000436	0.00128	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000434	0.00127	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000431	0.00126	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000426	0.00125	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000424	0.00124	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000417	0.00122	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000415	0.00121	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000414	0.00121	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000401	0.00117	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000398	0.00116	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000394	0.00115	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000389	0.00114	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000377	0.0011	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000367	0.00107	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000362	0.00106	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000341	0.000998	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000336	0.000983	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000328	0.000957	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000323	0.000943	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000299	0.000874	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000297	0.000868	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000287	0.00084	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000284	0.000831	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000281	0.000821	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000279	0.000816	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000279	0.000815	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000276	0.000806	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000274	0.000801	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000269	0.000787	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000268	0.000783	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000268	0.000782	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000266	0.000779	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000266	0.000777	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000263	0.000769	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000263	0.000768	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000258	0.000756	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000257	0.000751	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000252	0.000737	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00023	0.000671	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000227	0.000662	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000223	0.000653	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00022	0.000644	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000219	0.00064	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000216	0.00063	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000213	0.000623	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00021	0.000614	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000184	0.000539	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000179	0.000523	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000176	0.000514	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000173	0.000505	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000172	0.000502	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000169	0.000493	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000147	0.000431	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000114	0.000335	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000114	0.000335	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.73e-05	0.000284	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CA1—esophageal cancer	9.73e-05	0.000284	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CA2—esophageal cancer	8.9e-05	0.00026	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.27e-05	0.000242	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ADH7—esophageal cancer	8.27e-05	0.000242	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.25e-05	0.000212	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TYMP—esophageal cancer	6.93e-05	0.000203	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.74e-05	0.000197	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.57e-05	0.000192	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.27e-05	0.000183	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TPI1—esophageal cancer	6.27e-05	0.000183	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.01e-05	0.000176	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.79e-05	0.000169	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.73e-05	0.000168	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GNG7—esophageal cancer	5.45e-05	0.000159	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.11e-05	0.000149	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.86e-05	0.000142	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.81e-05	0.00014	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.56e-05	0.000133	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ENO1—esophageal cancer	4.56e-05	0.000133	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PSME1—esophageal cancer	4.49e-05	0.000131	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PSME2—esophageal cancer	4.49e-05	0.000131	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.87e-05	0.000113	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.64e-05	0.000106	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.32e-05	9.71e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.19e-05	9.32e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.13e-05	6.23e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NOS3—esophageal cancer	1.91e-05	5.58e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.75e-05	5.1e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—EP300—esophageal cancer	1.45e-05	4.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.07e-05	3.14e-05	CbGpPWpGaD
